{
  "DOI": "10.1007/s00439-012-1172-4",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-012-1172-4",
  "alternative-id": [
    "1172"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Levran",
      "given": "Orna",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Yuferov",
      "given": "Vadim",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kreek",
      "given": "Mary Jeanne",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2012,
        4,
        30
      ]
    ],
    "date-time": "2012-04-30T09:32:54Z",
    "timestamp": 1335778374000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ],
    "date-time": "2024-04-24T00:53:14Z",
    "timestamp": 1713919994000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        5,
        1
      ]
    ],
    "date-time": "2024-05-01T13:29:45Z",
    "timestamp": 1714570185122
  },
  "is-referenced-by-count": 86,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2012,
        5,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2012,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2012,
            5,
            1
          ]
        ],
        "date-time": "2012-05-01T00:00:00Z",
        "timestamp": 1335830400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-012-1172-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s00439-012-1172-4/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s00439-012-1172-4",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "823-842",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2012,
        5,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2012,
        5,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1001/archpsyc.65.2.135",
      "author": "RF Anton",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "journal-title": "Arch Gen Psychiatry",
      "key": "1172_CR1",
      "unstructured": "Anton RF, Oroszi G, O’Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study. Arch Gen Psychiatry 65:135–144",
      "volume": "65",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.drugalcdep.2005.11.024",
      "author": "A Arias",
      "doi-asserted-by": "crossref",
      "first-page": "262",
      "journal-title": "Drug Alcohol Depend",
      "key": "1172_CR2",
      "unstructured": "Arias A, Feinn R, Kranzler HR (2006) Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend 83:262–268",
      "volume": "83",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1530-0277.2008.00735.x",
      "author": "AJ Arias",
      "doi-asserted-by": "crossref",
      "first-page": "1159",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR3",
      "unstructured": "Arias AJ, Armeli S, Gelernter J, Covault J, Kallio A, Karhuvaara S, Koivisto T, Makela R, Kranzler HR (2008) Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. Alcohol Clin Exp Res 32:1159–1166",
      "volume": "32",
      "year": "2008"
    },
    {
      "DOI": "10.1093/molbev/msp276",
      "author": "CC Babbitt",
      "doi-asserted-by": "crossref",
      "first-page": "465",
      "journal-title": "Mol Biol Evol",
      "key": "1172_CR4",
      "unstructured": "Babbitt CC, Silverman JS, Haygood R, Reininga JM, Rockman MV, Wray GA (2010) Multiple functional variants in cis modulate PDYN expression. Mol Biol Evol 27:465–479",
      "volume": "27",
      "year": "2010"
    },
    {
      "DOI": "10.1001/archpsyc.64.3.369",
      "author": "CS Barr",
      "doi-asserted-by": "crossref",
      "first-page": "369",
      "journal-title": "Arch Gen Psychiatry",
      "key": "1172_CR5",
      "unstructured": "Barr CS, Schwandt M, Lindell SG, Chen SA, Goldman D, Suomi SJ, Higley JD, Heilig M (2007) Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry 64:369–376",
      "volume": "64",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.biopsych.2009.07.026",
      "author": "CS Barr",
      "doi-asserted-by": "crossref",
      "first-page": "78",
      "journal-title": "Biol Psychiatry",
      "key": "1172_CR6",
      "unstructured": "Barr CS, Chen SA, Schwandt ML, Lindell SG, Sun H, Suomi SJ, Heilig M (2010) Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus. Biol Psychiatry 67:78–80",
      "volume": "67",
      "year": "2010"
    },
    {
      "DOI": "10.1038/sj.mp.4001504",
      "author": "G Bart",
      "doi-asserted-by": "crossref",
      "first-page": "547",
      "journal-title": "Mol Psychiatry",
      "key": "1172_CR7",
      "unstructured": "Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J, Kreek MJ (2004) Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry 9:547–549",
      "volume": "9",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.npp.1300598",
      "author": "G Bart",
      "doi-asserted-by": "crossref",
      "first-page": "417",
      "journal-title": "Neuropsychopharmacology",
      "key": "1172_CR8",
      "unstructured": "Bart G, Kreek MJ, Ott J, LaForge KS, Proudnikov D, Pollak L, Heilig M (2005) Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 30:417–422",
      "volume": "30",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.npp.1301128",
      "author": "G Bart",
      "doi-asserted-by": "crossref",
      "first-page": "2313",
      "journal-title": "Neuropsychopharmacology",
      "key": "1172_CR9",
      "unstructured": "Bart G, LaForge KS, Borg L, Lilly C, Ho A, Kreek MJ (2006) Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the mu opioid receptor gene. Neuropsychopharmacology 31:2313–2317",
      "volume": "31",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.ejpain.2006.06.004",
      "author": "B Bayerer",
      "doi-asserted-by": "crossref",
      "first-page": "421",
      "journal-title": "Eur J Pain",
      "key": "1172_CR10",
      "unstructured": "Bayerer B, Stamer U, Hoeft A, Stuber F (2007) Genomic variations and transcriptional regulation of the human mu-opioid receptor gene. Eur J Pain 11:421–427",
      "volume": "11",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.biopsych.2010.02.010",
      "author": "D Bebawy",
      "doi-asserted-by": "crossref",
      "first-page": "223",
      "journal-title": "Biol Psychiatry",
      "key": "1172_CR11",
      "unstructured": "Bebawy D, Marquez P, Samboul S, Parikh D, Hamid A, Lutfy K (2010) Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice. Biol Psychiatry 68:223–230",
      "volume": "68",
      "year": "2010"
    },
    {
      "DOI": "10.1074/jbc.M006352200",
      "author": "K Befort",
      "doi-asserted-by": "crossref",
      "first-page": "3130",
      "journal-title": "J Biol Chem",
      "key": "1172_CR12",
      "unstructured": "Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C, Hoehe MR, Kieffer BL (2001) A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem 276:3130–3137",
      "volume": "276",
      "year": "2001"
    },
    {
      "DOI": "10.1038/sj.mp.4000331",
      "author": "AW Bergen",
      "doi-asserted-by": "crossref",
      "first-page": "490",
      "journal-title": "Mol Psychiatry",
      "key": "1172_CR13",
      "unstructured": "Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M, Goldman D (1997) Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry 2:490–494",
      "volume": "2",
      "year": "1997"
    },
    {
      "DOI": "10.1111/j.1471-4159.2004.02340.x",
      "author": "A Beyer",
      "doi-asserted-by": "crossref",
      "first-page": "553",
      "journal-title": "J Neurochem",
      "key": "1172_CR14",
      "unstructured": "Beyer A, Koch T, Schroder H, Schulz S, Hollt V (2004) Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem 89:553–560",
      "volume": "89",
      "year": "2004"
    },
    {
      "DOI": "10.1073/pnas.95.16.9608",
      "author": "C Bond",
      "doi-asserted-by": "crossref",
      "first-page": "9608",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1172_CR15",
      "unstructured": "Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95:9608–9613",
      "volume": "95",
      "year": "1998"
    },
    {
      "DOI": "10.1002/ajmg.b.30936",
      "author": "CA Bousman",
      "doi-asserted-by": "crossref",
      "first-page": "1025",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "1172_CR16",
      "unstructured": "Bousman CA, Glatt SJ, Everall IP, Tsuang MT (2009) Genetic association studies of methamphetamine use disorders: a systematic review and synthesis. Am J Med Genet B Neuropsychiatr Genet 150B:1025–1049",
      "volume": "150B",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.psychres.2009.07.019",
      "doi-asserted-by": "crossref",
      "key": "1172_CR1000",
      "unstructured": "Bousman CA, Glatt SJ, Cherner M, Atkinson JH, Grant I, Tsuang MT, Everall IP (2010) Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res 178:295–298"
    },
    {
      "DOI": "10.1097/YPG.0b013e32833511f6",
      "author": "JA Briant",
      "doi-asserted-by": "crossref",
      "first-page": "65",
      "journal-title": "Psychiatr Genet",
      "key": "1172_CR17",
      "unstructured": "Briant JA, Nielsen DA, Proudnikov D, Londono D, Ho A, Ott J, Kreek MJ (2010) Evidence for association of two variants of the nociceptin/orphanin FQ receptor gene OPRL1 with vulnerability to develop opiate addiction in Caucasians. Psychiatr Genet 20:65–72",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.brainres.2009.08.062",
      "author": "MR Bruchas",
      "doi-asserted-by": "crossref",
      "first-page": "44",
      "journal-title": "Brain Res",
      "key": "1172_CR18",
      "unstructured": "Bruchas MR, Land BB, Chavkin C (2010) The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 1314:44–55",
      "volume": "1314",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ng1113",
      "author": "LL Cavalli-Sforza",
      "doi-asserted-by": "crossref",
      "first-page": "266",
      "issue": "Suppl",
      "journal-title": "Nat Genet",
      "key": "1172_CR19",
      "unstructured": "Cavalli-Sforza LL, Feldman MW (2003) The application of molecular genetic approaches to the study of human evolution. Nat Genet 33(Suppl):266–275",
      "volume": "33",
      "year": "2003"
    },
    {
      "DOI": "10.1523/JNEUROSCI.0854-05.2005",
      "author": "VI Chefer",
      "doi-asserted-by": "crossref",
      "first-page": "5029",
      "journal-title": "J Neurosci",
      "key": "1172_CR20",
      "unstructured": "Chefer VI, Czyzyk T, Bolan EA, Moron J, Pintar JE, Shippenberg TS (2005) Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. J Neurosci 25:5029–5037",
      "volume": "25",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ajmg.10362",
      "author": "AC Chen",
      "doi-asserted-by": "crossref",
      "first-page": "429",
      "journal-title": "Am J Med Genet",
      "key": "1172_CR21",
      "unstructured": "Chen AC, LaForge KS, Ho A, McHugh PF, Kellogg S, Bell K, Schluger RP, Leal SM, Kreek MJ (2002) Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse. Am J Med Genet 114:429–435",
      "volume": "114",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.bbrc.2006.03.084",
      "author": "HS Choi",
      "doi-asserted-by": "crossref",
      "first-page": "1132",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "1172_CR22",
      "unstructured": "Choi HS, Kim CS, Hwang CK, Song KY, Wang W, Qiu Y, Law PY, Wei LN, Loh HH (2006) The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor. Biochem Biophys Res Commun 343:1132–1140",
      "volume": "343",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.npp.1300856",
      "author": "RY Chong",
      "doi-asserted-by": "crossref",
      "first-page": "204",
      "journal-title": "Neuropsychopharmacology",
      "key": "1172_CR23",
      "unstructured": "Chong RY, Oswald L, Yang X, Uhart M, Lin PI, Wand GS (2006) The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology 31:204–211",
      "volume": "31",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1369-1600.2009.00151.x",
      "author": "TK Clarke",
      "doi-asserted-by": "crossref",
      "first-page": "366",
      "journal-title": "Addict Biol",
      "key": "1172_CR24",
      "unstructured": "Clarke TK, Krause K, Li T, Schumann G (2009) An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. Addict Biol 14:366–370",
      "volume": "14",
      "year": "2009"
    },
    {
      "DOI": "10.1097/00001756-199904060-00042",
      "author": "DE Comings",
      "doi-asserted-by": "crossref",
      "first-page": "1133",
      "journal-title": "NeuroReport",
      "key": "1172_CR25",
      "unstructured": "Comings DE, Blake H, Dietz G, Gade-Andavolu R, Legro RS, Saucier G, Johnson P, Verde R, MacMurray JP (1999) The proenkephalin gene (PENK) and opioid dependence. NeuroReport 10:1133–1135",
      "volume": "10",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.pnpbp.2008.07.009",
      "author": "S Crettol",
      "doi-asserted-by": "crossref",
      "first-page": "1722",
      "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry",
      "key": "1172_CR26",
      "unstructured": "Crettol S, Besson J, Croquette-Krokar M, Hammig R, Gothuey I, Monnat M, Deglon JJ, Preisig M, Eap CB (2008) Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment. Prog Neuropsychopharmacol Biol Psychiatry 32:1722–1727",
      "volume": "32",
      "year": "2008"
    },
    {
      "DOI": "10.1097/00041444-200309000-00006",
      "author": "JJ Crowley",
      "doi-asserted-by": "crossref",
      "first-page": "169",
      "journal-title": "Psychiatr Genet",
      "key": "1172_CR27",
      "unstructured": "Crowley JJ, Oslin DW, Patkar AA, Gottheil E, DeMaria PA Jr, O’Brien CP, Berrettini WH, Grice DE (2003) A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet 13:169–173",
      "volume": "13",
      "year": "2003"
    },
    {
      "DOI": "10.1159/000320968",
      "author": "P Cruz-Gordillo",
      "doi-asserted-by": "crossref",
      "first-page": "154",
      "journal-title": "Brain Behav Evol",
      "key": "1172_CR28",
      "unstructured": "Cruz-Gordillo P, Fedrigo O, Wray GA, Babbitt CC (2010) Extensive changes in the expression of the opioid genes between humans and chimpanzees. Brain Behav Evol 76:154–162",
      "volume": "76",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1369-1600.2010.00265.x",
      "doi-asserted-by": "crossref",
      "key": "1172_CR29",
      "unstructured": "Crystal HA, Hamon S, Randesi M, Cook J, Anastos K, Lazar J, Liu C, Pearce L, Golub E, Valcour V, Weber KM, Holman S, Ho A, Kreek MJ (2012) A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women. Addict Biol 17:181–191"
    },
    {
      "DOI": "10.1016/S0026-0495(97)90289-4",
      "author": "JA Culpepper-Morgan",
      "doi-asserted-by": "crossref",
      "first-page": "130",
      "journal-title": "Metabolism",
      "key": "1172_CR30",
      "unstructured": "Culpepper-Morgan JA, Kreek MJ (1997) Hypothalamic–pituitary–adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal. Metabolism 46:130–134",
      "volume": "46",
      "year": "1997"
    },
    {
      "DOI": "10.1002/ajmg.b.30238",
      "author": "JP Dahl",
      "doi-asserted-by": "crossref",
      "first-page": "106",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "1172_CR31",
      "unstructured": "Dahl JP, Weller AE, Kampman KM, Oslin DW, Lohoff FW, Ferraro TN, O’Brien CP, Berrettini WH (2005) Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence. Am J Med Genet B Neuropsychiatr Genet 139B:106–108",
      "volume": "139B",
      "year": "2005"
    },
    {
      "DOI": "10.1111/j.1471-4159.2009.06472.x",
      "author": "I Deb",
      "doi-asserted-by": "crossref",
      "first-page": "486",
      "journal-title": "J Neurochem",
      "key": "1172_CR32",
      "unstructured": "Deb I, Chakraborty J, Gangopadhyay PK, Choudhury SR, Das S (2010) Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. J Neurochem 112:486–496",
      "volume": "112",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1601-183X.2010.00655.x",
      "author": "AM Dlugos",
      "doi-asserted-by": "crossref",
      "first-page": "199",
      "journal-title": "Genes Brain Behav",
      "key": "1172_CR33",
      "unstructured": "Dlugos AM, Hamidovic A, Hodgkinson C, Shen PH, Goldman D, Palmer AA, de Wit H (2011) OPRM1 gene variants modulate amphetamine-induced euphoria in humans. Genes Brain Behav 10:199–209",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1749-6632.2010.05928.x",
      "author": "RM Dores",
      "doi-asserted-by": "crossref",
      "first-page": "34",
      "journal-title": "Ann N Y Acad Sci",
      "key": "1172_CR34",
      "unstructured": "Dores RM, Baron AJ (2011) Evolution of POMC: origin, phylogeny, posttranslational processing, and the melanocortins. Ann N Y Acad Sci 1220:34–48",
      "volume": "1220",
      "year": "2011"
    },
    {
      "DOI": "10.1073/pnas.0600871103",
      "author": "K Drakenberg",
      "doi-asserted-by": "crossref",
      "first-page": "7883",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1172_CR35",
      "unstructured": "Drakenberg K, Nikoshkov A, Horvath MC, Fagergren P, Gharibyan A, Saarelainen K, Rahman S, Nylander I, Bakalkin G, Rajs J, Keller E, Hurd YL (2006) Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proc Natl Acad Sci USA 103:7883–7888",
      "volume": "103",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1369-1600.2011.00313.x",
      "doi-asserted-by": "crossref",
      "key": "1172_CR36",
      "unstructured": "Ducat E, Ray B, Bart G, Umemura Y, Varon J, Ho A, Kreek MJ (2011) Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyrapone. Addict Biol (in press)"
    },
    {
      "DOI": "10.1093/hmg/ddn068",
      "author": "HJ Edenberg",
      "doi-asserted-by": "crossref",
      "first-page": "1783",
      "journal-title": "Hum Mol Genet",
      "key": "1172_CR37",
      "unstructured": "Edenberg HJ, Wang J, Tian H, Pochareddy S, Xuei X, Wetherill L, Goate A, Hinrichs T, Kuperman S, Nurnberger JI Jr, Schuckit M, Tischfield JA, Foroud T (2008) A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence. Hum Mol Genet 17:1783–1789",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1186/1471-2350-9-35",
      "author": "CL Ehlers",
      "doi-asserted-by": "crossref",
      "first-page": "35",
      "journal-title": "BMC Med Genet",
      "key": "1172_CR38",
      "unstructured": "Ehlers CL, Lind PA, Wilhelmsen KC (2008) Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians. BMC Med Genet 9:35",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1097/01.ALC.0000106303.41755.B8",
      "author": "W Loh el",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR39",
      "unstructured": "el Loh W, Fann CS, Chang YT, Chang CJ, Cheng AT (2004) Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. Alcohol Clin Exp Res 28:15–19",
      "volume": "28",
      "year": "2004"
    },
    {
      "DOI": "10.1111/j.1530-0277.2008.00692.x",
      "author": "FM Filbey",
      "doi-asserted-by": "crossref",
      "first-page": "1113",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR40",
      "unstructured": "Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE (2008) Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res 32:1113–1123",
      "volume": "32",
      "year": "2008"
    },
    {
      "DOI": "10.1002/(SICI)1096-8628(19991015)88:5\u003c462::AID-AJMG4\u003e3.0.CO;2-S",
      "author": "P Franke",
      "doi-asserted-by": "crossref",
      "first-page": "462",
      "journal-title": "Am J Med Genet",
      "key": "1172_CR41",
      "unstructured": "Franke P, Nothen MM, Wang T, Neidt H, Knapp M, Lichtermann D, Weiffenbach O, Mayer P, Hollt V, Propping P, Maier W (1999) Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence. Am J Med Genet 88:462–464",
      "volume": "88",
      "year": "1999"
    },
    {
      "DOI": "10.1002/1096-8628(20010108)105:1\u003c114::AID-AJMG1074\u003e3.0.CO;2-L",
      "author": "P Franke",
      "doi-asserted-by": "crossref",
      "first-page": "114",
      "journal-title": "Am J Med Genet",
      "key": "1172_CR42",
      "unstructured": "Franke P, Wang T, Nothen MM, Knapp M, Neidt H, Albrecht S, Jahnes E, Propping P, Maier W (2001) Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am J Med Genet 105:114–119",
      "volume": "105",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.peptides.2007.04.012",
      "author": "EC Gavioli",
      "doi-asserted-by": "crossref",
      "first-page": "1229",
      "journal-title": "Peptides",
      "key": "1172_CR43",
      "unstructured": "Gavioli EC, Rizzi A, Marzola G, Zucchini S, Regoli D, Calo G (2007) Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides 28:1229–1239",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1530-0277.1997.tb04456.x",
      "author": "T Geijer",
      "doi-asserted-by": "crossref",
      "first-page": "1333",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR44",
      "unstructured": "Geijer T, Jonsson E, Neiman J, Gyllander A, Sedvall G, Rydberg U, Terenius L (1997) Prodynorphin allelic distribution in Scandinavian chronic alcoholics. Alcohol Clin Exp Res 21:1333–1336",
      "volume": "21",
      "year": "1997"
    },
    {
      "DOI": "10.1038/sj.mp.4000556",
      "author": "J Gelernter",
      "doi-asserted-by": "crossref",
      "first-page": "476",
      "journal-title": "Mol Psychiatry",
      "key": "1172_CR45",
      "unstructured": "Gelernter J, Kranzler H, Cubells J (1999) Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry 4:476–483",
      "volume": "4",
      "year": "1999"
    },
    {
      "DOI": "10.1111/j.1530-0277.2007.00339.x",
      "author": "J Gelernter",
      "doi-asserted-by": "crossref",
      "first-page": "555",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR46",
      "unstructured": "Gelernter J, Gueorguieva R, Kranzler HR, Zhang H, Cramer J, Rosenheck R, Krystal JH (2007) Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res 31:555–563",
      "volume": "31",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ajmg.b.30510",
      "author": "G Gerra",
      "doi-asserted-by": "crossref",
      "first-page": "771",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "1172_CR47",
      "unstructured": "Gerra G, Leonardi C, Cortese E, D’Amore A, Lucchini A, Strepparola G, Serio G, Farina G, Magnelli F, Zaimovic A, Mancini A, Turci M, Manfredini M, Donnini C (2007) Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am J Med Genet B Neuropsychiatr Genet 144:771–775",
      "volume": "144",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s00213-009-1730-1",
      "author": "A Gieryk",
      "doi-asserted-by": "crossref",
      "first-page": "291",
      "journal-title": "Psychopharmacology",
      "key": "1172_CR48",
      "unstructured": "Gieryk A, Ziolkowska B, Solecki W, Kubik J, Przewlocki R (2010) Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity. Psychopharmacology 208:291–300",
      "volume": "208",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.drugalcdep.2007.02.022",
      "author": "SJ Glatt",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "journal-title": "Drug Alcohol Depend",
      "key": "1172_CR49",
      "unstructured": "Glatt SJ, Bousman C, Wang RS, Murthy KK, Rana BK, Lasky-Su JA, Zhu SC, Zhang R, Li J, Zhang B, Li J, Lyons MJ, Faraone SV, Tsuang MT (2007) Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug Alcohol Depend 90:159–165",
      "volume": "90",
      "year": "2007"
    },
    {
      "DOI": "10.1211/0022357001773652",
      "author": "N Gscheidel",
      "doi-asserted-by": "crossref",
      "first-page": "27",
      "journal-title": "Pol J Pharmacol",
      "key": "1172_CR50",
      "unstructured": "Gscheidel N, Sander T, Wendel B, Heere P, Schmidt LG, Rommelspacher H, Hoehe MR, Samochowiec J (2000) Five exon 1 variants of mu opioid receptor and vulnerability to alcohol dependence. Pol J Pharmacol 52:27–31",
      "volume": "52",
      "year": "2000"
    },
    {
      "DOI": "10.1002/ajmg.b.10054",
      "author": "CA Hernandez-Avila",
      "doi-asserted-by": "crossref",
      "first-page": "60",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "1172_CR51",
      "unstructured": "Hernandez-Avila CA, Wand G, Luo X, Gelernter J, Kranzler HR (2003) Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet 118:60–65",
      "volume": "118",
      "year": "2003"
    },
    {
      "DOI": "10.1097/FPC.0b013e3282f0b99c",
      "author": "CA Hernandez-Avila",
      "doi-asserted-by": "crossref",
      "first-page": "1031",
      "journal-title": "Pharmacogenet Genomics",
      "key": "1172_CR52",
      "unstructured": "Hernandez-Avila CA, Covault J, Wand G, Zhang H, Gelernter J, Kranzler HR (2007) Population-specific effects of the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1) on HPA-axis activation. Pharmacogenet Genomics 17:1031–1038",
      "volume": "17",
      "year": "2007"
    },
    {
      "DOI": "10.1093/alcalc/agn032",
      "author": "CA Hodgkinson",
      "doi-asserted-by": "crossref",
      "first-page": "505",
      "journal-title": "Alcohol Alcohol",
      "key": "1172_CR53",
      "unstructured": "Hodgkinson CA, Yuan Q, Xu K, Shen PH, Heinz E, Lobos EA, Binder EB, Cubells J, Ehlers CL, Gelernter J, Mann J, Riley B, Roy A, Tabakoff B, Todd RD, Zhou Z, Goldman D (2008) Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43:505–515",
      "volume": "43",
      "year": "2008"
    },
    {
      "DOI": "10.1093/hmg/9.19.2895",
      "author": "MR Hoehe",
      "doi-asserted-by": "crossref",
      "first-page": "2895",
      "journal-title": "Hum Mol Genet",
      "key": "1172_CR54",
      "unstructured": "Hoehe MR, Kopke K, Wendel B, Rohde K, Flachmeier C, Kidd KK, Berrettini WH, Church GM (2000) Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet 9:2895–2908",
      "volume": "9",
      "year": "2000"
    },
    {
      "DOI": "10.1111/j.1369-1600.2007.00089.x",
      "author": "J Huang",
      "doi-asserted-by": "crossref",
      "first-page": "88",
      "journal-title": "Addict Biol",
      "key": "1172_CR55",
      "unstructured": "Huang J, Young B, Pletcher MT, Heilig M, Wahlestedt C (2008) Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence. Addict Biol 13:88–94",
      "volume": "13",
      "year": "2008"
    },
    {
      "DOI": "10.1196/annals.1316.039",
      "author": "S Ide",
      "doi-asserted-by": "crossref",
      "first-page": "316",
      "journal-title": "Ann N Y Acad Sci",
      "key": "1172_CR56",
      "unstructured": "Ide S, Kobayashi H, Tanaka K, Ujike H, Sekine Y, Ozaki N, Inada T, Harano M, Komiyama T, Yamada M, Iyo M, Ikeda K, Sora I (2004) Gene polymorphisms of the mu opioid receptor in methamphetamine abusers. Ann N Y Acad Sci 1025:316–324",
      "volume": "1025",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.tpj.6500355",
      "author": "S Ide",
      "doi-asserted-by": "crossref",
      "first-page": "179",
      "journal-title": "Pharmacogenomics J",
      "key": "1172_CR57",
      "unstructured": "Ide S, Kobayashi H, Ujike H, Ozaki N, Sekine Y, Inada T, Harano M, Komiyama T, Yamada M, Iyo M, Iwata N, Tanaka K, Shen H, Iwahashi K, Itokawa M, Minami M, Satoh M, Ikeda K, Sora I (2006) Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms. Pharmacogenomics J 6:179–188",
      "volume": "6",
      "year": "2006"
    },
    {
      "DOI": "10.1006/jmbi.2000.4212",
      "author": "E Ito",
      "doi-asserted-by": "crossref",
      "first-page": "259",
      "journal-title": "J Mol Biol",
      "key": "1172_CR58",
      "unstructured": "Ito E, Xie G, Maruyama K, Palmer PP (2000) A core-promoter region functions bi-directionally for human opioid-receptor-like gene ORL1 and its 5′-adjacent gene GAIP. J Mol Biol 304:259–270",
      "volume": "304",
      "year": "2000"
    },
    {
      "DOI": "10.1176/appi.ajp.2008.08020304",
      "author": "N Jayaram-Lindstrom",
      "doi-asserted-by": "crossref",
      "first-page": "1442",
      "journal-title": "Am J Psychiatry",
      "key": "1172_CR59",
      "unstructured": "Jayaram-Lindstrom N, Hammarberg A, Beck O, Franck J (2008a) Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. Am J Psychiatry 165:1442–1448",
      "volume": "165",
      "year": "2008"
    },
    {
      "DOI": "10.1038/sj.npp.1301572",
      "author": "N Jayaram-Lindstrom",
      "doi-asserted-by": "crossref",
      "first-page": "1856",
      "journal-title": "Neuropsychopharmacology",
      "key": "1172_CR60",
      "unstructured": "Jayaram-Lindstrom N, Konstenius M, Eksborg S, Beck O, Hammarberg A, Franck J (2008b) Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. Neuropsychopharmacology 33:1856–1863",
      "volume": "33",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.biopsych.2007.05.001",
      "author": "J Kakko",
      "doi-asserted-by": "crossref",
      "first-page": "172",
      "journal-title": "Biol Psychiatry",
      "key": "1172_CR61",
      "unstructured": "Kakko J, von Wachenfeldt J, Svanborg KD, Lidstrom J, Barr CS, Heilig M (2008) Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence. Biol Psychiatry 63:172–177",
      "volume": "63",
      "year": "2008"
    },
    {
      "DOI": "10.1142/S0219635207001635",
      "author": "S Kapur",
      "doi-asserted-by": "crossref",
      "first-page": "511",
      "journal-title": "J Integr Neurosci",
      "key": "1172_CR62",
      "unstructured": "Kapur S, Sharad S, Singh RA, Gupta AK (2007) A118G polymorphism in mu opioid receptor gene (OPRM1): association with opiate addiction in subjects of Indian origin. J Integr Neurosci 6:511–522",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0376-8716(02)00308-3",
      "author": "SH Kellogg",
      "doi-asserted-by": "crossref",
      "first-page": "137",
      "journal-title": "Drug Alcohol Depend",
      "key": "1172_CR63",
      "unstructured": "Kellogg SH, McHugh PF, Bell K, Schluger JH, Schluger RP, LaForge KS, Ho A, Kreek MJ (2003) The Kreek–McHugh–Schluger–Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend 69:137–150",
      "volume": "69",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s00213-002-1255-3",
      "author": "F Kiefer",
      "doi-asserted-by": "crossref",
      "first-page": "239",
      "journal-title": "Psychopharmacology",
      "key": "1172_CR64",
      "unstructured": "Kiefer F, Jahn H, Schick M, Wiedemann K (2002) Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship. Psychopharmacology 164:239–240",
      "volume": "164",
      "year": "2002"
    },
    {
      "DOI": "10.1097/01.ALC.0000130803.62768.AB",
      "author": "SG Kim",
      "doi-asserted-by": "crossref",
      "first-page": "986",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR65",
      "unstructured": "Kim SG, Kim CM, Kang DH, Kim YJ, Byun WT, Kim SY, Park JM, Kim MJ, Oslin DW (2004) Association of functional opioid receptor genotypes with alcohol dependence in Koreans. Alcohol Clin Exp Res 28:986–990",
      "volume": "28",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0893-133X(01)00416-X",
      "author": "AC King",
      "doi-asserted-by": "crossref",
      "first-page": "778",
      "journal-title": "Neuropsychopharmacology",
      "key": "1172_CR66",
      "unstructured": "King AC, Schluger J, Gunduz M, Borg L, Perret G, Ho A, Kreek MJ (2002) Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology 26:778–788",
      "volume": "26",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.brainres.2009.09.074",
      "author": "AT Knoll",
      "doi-asserted-by": "crossref",
      "first-page": "56",
      "journal-title": "Brain Res",
      "key": "1172_CR67",
      "unstructured": "Knoll AT, Carlezon WA Jr (2010) Dynorphin, stress, and depression. Brain Res 1314:56–73",
      "volume": "1314",
      "year": "2010"
    },
    {
      "DOI": "10.1002/ajmg.b.30337",
      "author": "H Kobayashi",
      "doi-asserted-by": "crossref",
      "first-page": "482",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "1172_CR68",
      "unstructured": "Kobayashi H, Hata H, Ujike H, Harano M, Inada T, Komiyama T, Yamada M, Sekine Y, Iwata N, Iyo M, Ozaki N, Itokawa M, Naka M, Ide S, Ikeda K, Numachi Y, Sora I (2006) Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosis. Am J Med Genet B Neuropsychiatr Genet 141B:482–486",
      "volume": "141B",
      "year": "2006"
    },
    {
      "DOI": "10.1124/mol.58.2.328",
      "author": "T Koch",
      "doi-asserted-by": "crossref",
      "first-page": "328",
      "journal-title": "Mol Pharmacol",
      "key": "1172_CR69",
      "unstructured": "Koch T, Kroslak T, Averbeck M, Mayer P, Schroder H, Raulf E, Hollt V (2000) Allelic variation S268P of the human mu-opioid receptor affects both desensitization and G protein coupling. Mol Pharmacol 58:328–334",
      "volume": "58",
      "year": "2000"
    },
    {
      "DOI": "10.1176/appi.ajp.2007.05030503",
      "author": "G Koob",
      "doi-asserted-by": "crossref",
      "first-page": "1149",
      "journal-title": "Am J Psychiatry",
      "key": "1172_CR70",
      "unstructured": "Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164:1149–1159",
      "volume": "164",
      "year": "2007"
    },
    {
      "author": "HR Kranzler",
      "first-page": "1359",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR71",
      "unstructured": "Kranzler HR, Gelernter J, O’Malley S, Hernandez-Avila CA, Kaufman D (1998) Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1). Alcohol Clin Exp Res 22:1359–1362",
      "volume": "22",
      "year": "1998"
    },
    {
      "DOI": "10.1074/jbc.M107543200",
      "author": "J Kraus",
      "doi-asserted-by": "crossref",
      "first-page": "43901",
      "journal-title": "J Biol Chem",
      "key": "1172_CR72",
      "unstructured": "Kraus J, Borner C, Giannini E, Hickfang K, Braun H, Mayer P, Hoehe MR, Ambrosch A, Konig W, Hollt V (2001) Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 276:43901–43908",
      "volume": "276",
      "year": "2001"
    },
    {
      "DOI": "10.1124/mol.64.4.876",
      "author": "J Kraus",
      "doi-asserted-by": "crossref",
      "first-page": "876",
      "journal-title": "Mol Pharmacol",
      "key": "1172_CR73",
      "unstructured": "Kraus J, Borner C, Giannini E, Hollt V (2003) The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol 64:876–884",
      "volume": "64",
      "year": "2003"
    },
    {
      "DOI": "10.1001/jama.1973.03220060039009",
      "author": "MJ Kreek",
      "doi-asserted-by": "crossref",
      "first-page": "665",
      "journal-title": "JAMA",
      "key": "1172_CR74",
      "unstructured": "Kreek MJ (1973) Medical safety and side effects of methadone in tolerant individuals. JAMA 223:665–668",
      "volume": "223",
      "year": "1973"
    },
    {
      "DOI": "10.1016/S0376-8716(98)00064-7",
      "author": "MJ Kreek",
      "doi-asserted-by": "crossref",
      "first-page": "23",
      "journal-title": "Drug Alcohol Depend",
      "key": "1172_CR75",
      "unstructured": "Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51:23–47",
      "volume": "51",
      "year": "1998"
    },
    {
      "DOI": "10.1016/0024-3205(83)90529-5",
      "author": "MJ Kreek",
      "doi-asserted-by": "crossref",
      "first-page": "409",
      "issue": "Suppl 1",
      "journal-title": "Life Sci",
      "key": "1172_CR76",
      "unstructured": "Kreek MJ, Wardlaw SL, Hartman N, Raghunath J, Friedman J, Schneider B, Frantz AG (1983) Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans. Life Sci 33(Suppl 1):409–411",
      "volume": "33",
      "year": "1983"
    },
    {
      "DOI": "10.1038/nrd897",
      "author": "MJ Kreek",
      "doi-asserted-by": "crossref",
      "first-page": "710",
      "journal-title": "Nat Rev Drug Discov",
      "key": "1172_CR77",
      "unstructured": "Kreek MJ, LaForge KS, Butelman E (2002) Pharmacotherapy of addictions. Nat Rev Drug Discov 1:710–726",
      "volume": "1",
      "year": "2002"
    },
    {
      "DOI": "10.1124/pr.57.1.1",
      "author": "MJ Kreek",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Pharmacol Rev",
      "key": "1172_CR78",
      "unstructured": "Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA (2005) Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57:1–26",
      "volume": "57",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.coph.2008.12.016",
      "author": "MJ Kreek",
      "doi-asserted-by": "crossref",
      "first-page": "74",
      "journal-title": "Curr Opin Pharmacol",
      "key": "1172_CR79",
      "unstructured": "Kreek MJ, Zhou Y, Butelman ER, Levran O (2009) Opiate and cocaine addiction: from bench to clinic and back to the bench. Curr Opin Pharmacol 9:74–80",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1471-4159.2007.04738.x",
      "author": "T Kroslak",
      "doi-asserted-by": "crossref",
      "first-page": "77",
      "journal-title": "J Neurochem",
      "key": "1172_CR80",
      "unstructured": "Kroslak T, LaForge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ (2007) The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem 103:77–87",
      "volume": "103",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.brainres.2009.05.067",
      "author": "A Kuzmin",
      "doi-asserted-by": "crossref",
      "first-page": "S80",
      "issue": "Suppl",
      "journal-title": "Brain Res",
      "key": "1172_CR81",
      "unstructured": "Kuzmin A, Bazov I, Sheedy D, Garrick T, Harper C, Bakalkin G (2009) Expression of pronociceptin and its receptor is downregulated in the brain of human alcoholics. Brain Res 1305(Suppl):S80–S85",
      "volume": "1305",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0014-2999(00)00819-0",
      "author": "KS LaForge",
      "doi-asserted-by": "crossref",
      "first-page": "249",
      "journal-title": "Eur J Pharmacol",
      "key": "1172_CR82",
      "unstructured": "LaForge KS, Yuferov V, Kreek MJ (2000) Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur J Pharmacol 410:249–268",
      "volume": "410",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.biopsych.2010.10.021",
      "author": "J Merrer Le",
      "doi-asserted-by": "crossref",
      "first-page": "700",
      "journal-title": "Biol Psychiatry",
      "key": "1172_CR83",
      "unstructured": "Le Merrer J, Plaza-Zabala A, Del Boca C, Matifas A, Maldonado R, Kieffer BL (2011) Deletion of the delta opioid receptor gene impairs place conditioning but preserves morphine reinforcement. Biol Psychiatry 69:700–703",
      "volume": "69",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1600-0854.2008.00846.x",
      "author": "TT Leskela",
      "doi-asserted-by": "crossref",
      "first-page": "116",
      "journal-title": "Traffic",
      "key": "1172_CR84",
      "unstructured": "Leskela TT, Markkanen PM, Alahuhta IA, Tuusa JT, Petaja-Repo UE (2009) Phe27Cys polymorphism alters the maturation and subcellular localization of the human delta opioid receptor. Traffic 10:116–129",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1601-183X.2008.00410.x",
      "author": "O Levran",
      "doi-asserted-by": "crossref",
      "first-page": "720",
      "journal-title": "Genes Brain Behav",
      "key": "1172_CR85",
      "unstructured": "Levran O, Londono D, O’Hara K, Nielsen DA, Peles E, Rotrosen J, Casadonte P, Linzy S, Randesi M, Ott J, Adelson M, Kreek MJ (2008) Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav 7:720–729",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1601-183X.2009.00501.x",
      "author": "O Levran",
      "doi-asserted-by": "crossref",
      "first-page": "531",
      "journal-title": "Genes Brain Behav",
      "key": "1172_CR86",
      "unstructured": "Levran O, Londono D, O’Hara K, Randesi M, Rotrosen J, Casadonte P, Linzy S, Ott J, Adelson M, Kreek MJ (2009) Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav 8:531–540",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1038/jhg.2010.150",
      "author": "O Levran",
      "doi-asserted-by": "crossref",
      "first-page": "147",
      "journal-title": "J Hum Genet",
      "key": "1172_CR87",
      "unstructured": "Levran O, Awolesi O, Linzy S, Adelson M, Kreek MJ (2011) Haplotype block structure of the genomic region of the mu opioid receptor gene. J Hum Genet 56:147–155",
      "volume": "56",
      "year": "2011"
    },
    {
      "DOI": "10.1007/BF02338825",
      "author": "X Li",
      "doi-asserted-by": "crossref",
      "first-page": "179",
      "journal-title": "J Mol Evol",
      "key": "1172_CR88",
      "unstructured": "Li X, Keith DE Jr, Evans CJ (1996) Mu opioid receptor-like sequences are present throughout vertebrate evolution. J Mol Evol 43:179–184",
      "volume": "43",
      "year": "1996"
    },
    {
      "DOI": "10.1002/ajmg.b.20034",
      "author": "X Luo",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "1172_CR89",
      "unstructured": "Luo X, Kranzler HR, Zhao H, Gelernter J (2003) Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet B Neuropsychiatr Genet 120:97–108",
      "volume": "120",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.drugalcdep.2009.12.016",
      "author": "SD Mague",
      "doi-asserted-by": "crossref",
      "first-page": "172",
      "journal-title": "Drug Alcohol Depend",
      "key": "1172_CR90",
      "unstructured": "Mague SD, Blendy JA (2010) OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend 108:172–182",
      "volume": "108",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.0901800106",
      "author": "SD Mague",
      "doi-asserted-by": "crossref",
      "first-page": "10847",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1172_CR91",
      "unstructured": "Mague SD, Isiegas C, Huang P, Liu-Chen LY, Lerman C, Blendy JA (2009) Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci USA 106:10847–10852",
      "volume": "106",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.biopsych.2011.02.023",
      "author": "BS Maher",
      "doi-asserted-by": "crossref",
      "first-page": "519",
      "journal-title": "Biol Psychiatry",
      "key": "1172_CR92",
      "unstructured": "Maher BS, Vladimirov VI, Latendresse SJ, Thiselton DL, McNamee R, Kang M, Bigdeli TB, Chen X, Riley BP, Hettema JM, Chilcoat H, Heidbreder C, Muglia P, Murrelle EL, Dick DM, Aliev F, Agrawal A, Edenberg HJ, Kramer J, Nurnberger J, Tischfield JA, Devlin B, Ferrell RE, Kirillova GP, Tarter RE, Kendler KS, Vanyukov MM (2011) The AVPR1A gene and substance use disorders: association, replication, and functional evidence. Biol Psychiatry 70:519–527",
      "volume": "70",
      "year": "2011"
    },
    {
      "DOI": "10.1152/jn.01007.2006",
      "author": "W Margas",
      "doi-asserted-by": "crossref",
      "first-page": "1058",
      "journal-title": "J Neurophysiol",
      "key": "1172_CR93",
      "unstructured": "Margas W, Zubkoff I, Schuler HG, Janicki PK, Ruiz-Velasco V (2007) Modulation of Ca2+ channels by heterologously expressed wild-type and mutant human mu-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism. J Neurophysiol 97:1058–1067",
      "volume": "97",
      "year": "2007"
    },
    {
      "DOI": "10.1097/00001756-199707280-00025",
      "author": "P Mayer",
      "doi-asserted-by": "crossref",
      "first-page": "2547",
      "journal-title": "NeuroReport",
      "key": "1172_CR94",
      "unstructured": "Mayer P, Rochlitz H, Rauch E, Rommelspacher H, Hasse HE, Schmidt S, Hollt V (1997) Association between a delta opioid receptor gene polymorphism and heroin dependence in man. NeuroReport 8:2547–2550",
      "volume": "8",
      "year": "1997"
    },
    {
      "DOI": "10.1111/j.1530-0277.2006.00156.x",
      "author": "JE McGeary",
      "doi-asserted-by": "crossref",
      "first-page": "1288",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR95",
      "unstructured": "McGeary JE, Monti PM, Rohsenow DJ, Tidey J, Swift R, Miranda R Jr (2006) Genetic moderators of naltrexone’s effects on alcohol cue reactivity. Alcohol Clin Exp Res 30:1288–1296",
      "volume": "30",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.mp.4001378",
      "author": "GM Miller",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "journal-title": "Mol Psychiatry",
      "key": "1172_CR96",
      "unstructured": "Miller GM, Bendor J, Tiefenbacher S, Yang H, Novak MA, Madras BK (2004) A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression. Mol Psychiatry 9:99–108",
      "volume": "9",
      "year": "2004"
    },
    {
      "DOI": "10.1111/j.1530-0277.2009.01073.x",
      "author": "R Miranda",
      "doi-asserted-by": "crossref",
      "first-page": "112",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR97",
      "unstructured": "Miranda R, Ray L, Justus A, Meyerson LA, Knopik VS, McGeary J, Monti PM (2010) Initial evidence of an association between OPRM1 and adolescent alcohol misuse. Alcohol Clin Exp Res 34:112–122",
      "volume": "34",
      "year": "2010"
    },
    {
      "DOI": "10.2174/187152710790966713",
      "author": "NP Murphy",
      "doi-asserted-by": "crossref",
      "first-page": "87",
      "journal-title": "CNS Neurol Disord: Drug Targets",
      "key": "1172_CR98",
      "unstructured": "Murphy NP (2010) The nociceptin/orphanin FQ system as a target for treating alcoholism. CNS Neurol Disord: Drug Targets 9:87–93",
      "volume": "9",
      "year": "2010"
    },
    {
      "DOI": "10.1038/sj.mp.4002147",
      "author": "DA Nielsen",
      "doi-asserted-by": "crossref",
      "first-page": "417",
      "journal-title": "Mol Psychiatry",
      "key": "1172_CR99",
      "unstructured": "Nielsen DA, Ji F, Yuferov V, Ho A, Chen A, Levran O, Ott J, Kreek MJ (2008) Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Mol Psychiatry 13:417–428",
      "volume": "13",
      "year": "2008"
    },
    {
      "DOI": "10.1096/fj.05-3743fje",
      "author": "A Nikoshkov",
      "doi-asserted-by": "crossref",
      "first-page": "1543",
      "journal-title": "FASEB J",
      "key": "1172_CR100",
      "unstructured": "Nikoshkov A, Hurd YL, Yakovleva T, Bazov I, Marinova Z, Cebers G, Pasikova N, Gharibyan A, Terenius L, Bakalkin G (2005) Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain. FASEB J 19:1543–1545",
      "volume": "19",
      "year": "2005"
    },
    {
      "DOI": "10.1073/pnas.0710902105",
      "author": "A Nikoshkov",
      "doi-asserted-by": "crossref",
      "first-page": "786",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1172_CR101",
      "unstructured": "Nikoshkov A, Drakenberg K, Wang X, Horvath MC, Keller E, Hurd YL (2008) Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression. Proc Natl Acad Sci USA 105:786–791",
      "volume": "105",
      "year": "2008"
    },
    {
      "DOI": "10.1159/000093099",
      "author": "D Nishizawa",
      "doi-asserted-by": "crossref",
      "first-page": "137",
      "journal-title": "Neuropsychobiology",
      "key": "1172_CR102",
      "unstructured": "Nishizawa D, Han W, Hasegawa J, Ishida T, Numata Y, Sato T, Kawai A, Ikeda K (2006) Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population. Neuropsychobiology 53:137–141",
      "volume": "53",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.neulet.2006.02.038",
      "author": "A Nomura",
      "doi-asserted-by": "crossref",
      "first-page": "158",
      "journal-title": "Neurosci Lett",
      "key": "1172_CR103",
      "unstructured": "Nomura A, Ujike H, Tanaka Y, Otani K, Morita Y, Kishimoto M, Morio A, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y, Iwata N, Sora I, Iyo M, Ozaki N, Kuroda S (2006) Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence. Neurosci Lett 400:158–162",
      "volume": "400",
      "year": "2006"
    },
    {
      "author": "CP O’Brien",
      "first-page": "106",
      "journal-title": "Am J Addict",
      "key": "1172_CR104",
      "unstructured": "O’Brien CP, Gastfriend DR, Forman RF, Schweizer E, Pettinati HM (2011) Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone. Am J Addict 20:106–112",
      "volume": "20",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s002130100919",
      "author": "SS O’Malley",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "journal-title": "Psychopharmacology",
      "key": "1172_CR105",
      "unstructured": "O’Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis. Psychopharmacology 160:19–29",
      "volume": "160",
      "year": "2002"
    },
    {
      "DOI": "10.1074/jbc.M109.019414",
      "author": "T Ono",
      "doi-asserted-by": "crossref",
      "first-page": "20175",
      "journal-title": "J Biol Chem",
      "key": "1172_CR106",
      "unstructured": "Ono T, Kaneda T, Muto A, Yoshida T (2009a) Positive transcriptional regulation of the human mu opioid receptor gene by poly(ADP-ribose) polymerase-1 and increase of its DNA binding affinity based on polymorphism of G-172-\u003eT. J Biol Chem 284:20175–20183",
      "volume": "284",
      "year": "2009"
    },
    {
      "DOI": "10.1248/bpb.32.721",
      "author": "T Ono",
      "doi-asserted-by": "crossref",
      "first-page": "721",
      "journal-title": "Biol Pharm Bull",
      "key": "1172_CR107",
      "unstructured": "Ono T, Muto A, Kaneda T, Arita E, Yoshida T (2009b) Novel linkage disequilibrium of single nucleotide polymorphisms in the transcriptional regulatory region of mu-opioid receptor gene in Japanese population. Biol Pharm Bull 32:721–723",
      "volume": "32",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1530-0277.2008.00846.x",
      "author": "G Oroszi",
      "doi-asserted-by": "crossref",
      "first-page": "383",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR108",
      "unstructured": "Oroszi G, Anton RF, O’Malley S, Swift R, Pettinati H, Couper D, Yuan Q, Goldman D (2009) OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res 33:383–393",
      "volume": "33",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.npp.1300219",
      "author": "DW Oslin",
      "doi-asserted-by": "crossref",
      "first-page": "1546",
      "journal-title": "Neuropsychopharmacology",
      "key": "1172_CR109",
      "unstructured": "Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O’Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546–1552",
      "volume": "28",
      "year": "2003"
    },
    {
      "author": "YX Pan",
      "first-page": "65",
      "journal-title": "Methods Mol Med",
      "key": "1172_CR110",
      "unstructured": "Pan YX (2003) Identification of alternatively spliced variants from opioid receptor genes. Methods Mol Med 84:65–75",
      "volume": "84",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.biopsych.2008.05.008",
      "author": "I Racz",
      "doi-asserted-by": "crossref",
      "first-page": "989",
      "journal-title": "Biol Psychiatry",
      "key": "1172_CR111",
      "unstructured": "Racz I, Schurmann B, Karpushova A, Reuter M, Cichon S, Montag C, Furst R, Schutz C, Franke PE, Strohmaier J, Wienker TF, Terenius L, Osby U, Gunnar A, Maier W, Bilkei-Gorzo A, Nothen M, Zimmer A (2008) The opioid peptides enkephalin and beta-endorphin in alcohol dependence. Biol Psychiatry 64:989–997",
      "volume": "64",
      "year": "2008"
    },
    {
      "DOI": "10.1038/mp.2010.56",
      "author": "VA Ramchandani",
      "doi-asserted-by": "crossref",
      "first-page": "809",
      "journal-title": "Mol Psychiatry",
      "key": "1172_CR112",
      "unstructured": "Ramchandani VA, Umhau J, Pavon FJ, Ruiz-Velasco V, Margas W, Sun H, Damadzic R, Eskay R, Schoor M, Thorsell A, Schwandt ML, Sommer WH, George DT, Parsons LH, Herscovitch P, Hommer D, Heilig M (2011) A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 16:809–817",
      "volume": "16",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1530-0277.2010.01333.x",
      "author": "LA Ray",
      "doi-asserted-by": "crossref",
      "first-page": "166",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR113",
      "unstructured": "Ray LA (2011) Stress-induced and cue-induced craving for alcohol in heavy drinkers: preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcohol Clin Exp Res 35:166–174",
      "volume": "35",
      "year": "2011"
    },
    {
      "DOI": "10.1097/01.ALC.0000148114.34000.B9",
      "author": "LA Ray",
      "doi-asserted-by": "crossref",
      "first-page": "1789",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR114",
      "unstructured": "Ray LA, Hutchison KE (2004) A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28:1789–1795",
      "volume": "28",
      "year": "2004"
    },
    {
      "DOI": "10.1001/archpsyc.64.9.1069",
      "author": "LA Ray",
      "doi-asserted-by": "crossref",
      "first-page": "1069",
      "journal-title": "Arch Gen Psychiatry",
      "key": "1172_CR115",
      "unstructured": "Ray LA, Hutchison KE (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64:1069–1077",
      "volume": "64",
      "year": "2007"
    },
    {
      "DOI": "10.1097/00041444-200512000-00013",
      "author": "R Ray",
      "doi-asserted-by": "crossref",
      "first-page": "295",
      "journal-title": "Psychiatr Genet",
      "key": "1172_CR116",
      "unstructured": "Ray R, Doyle GA, Crowley JJ, Buono RJ, Oslin DW, Patkar AA, Mannelli P, DeMaria PA Jr, O’Brien CP, Berrettini WH (2005) A functional prodynorphin promoter polymorphism and opioid dependence. Psychiatr Genet 15:295–298",
      "volume": "15",
      "year": "2005"
    },
    {
      "DOI": "10.1111/j.1530-0277.2010.01233.x",
      "author": "LA Ray",
      "doi-asserted-by": "crossref",
      "first-page": "1479",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR117",
      "unstructured": "Ray LA, Hutchison KE, Ashenhurst JR, Morrow AL (2010) Naltrexone selectively elevates GABAergic neuroactive steroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation. Alcohol Clin Exp Res 34:1479–1487",
      "volume": "34",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.1018699108",
      "author": "R Ray",
      "doi-asserted-by": "crossref",
      "first-page": "9268",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1172_CR118",
      "unstructured": "Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C (2011) Human mu opioid receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci USA 108:9268–9273",
      "volume": "108",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pbio.0030387",
      "author": "MV Rockman",
      "doi-asserted-by": "crossref",
      "first-page": "e387",
      "journal-title": "PLoS Biol",
      "key": "1172_CR119",
      "unstructured": "Rockman MV, Hahn MW, Soranzo N, Zimprich F, Goldstein DB, Wray GA (2005) Ancient and recent positive selection transformed opioid cis-regulation in humans. PLoS Biol 3:e387",
      "volume": "3",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S0741-8329(01)00139-2",
      "author": "H Rommelspacher",
      "doi-asserted-by": "crossref",
      "first-page": "129",
      "journal-title": "Alcohol",
      "key": "1172_CR120",
      "unstructured": "Rommelspacher H, Smolka M, Schmidt LG, Samochowiec J, Hoehe MR (2001) Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals. Alcohol 24:129–135",
      "volume": "24",
      "year": "2001"
    },
    {
      "DOI": "10.1111/j.1369-1600.2010.00248.x",
      "author": "M Rouault",
      "doi-asserted-by": "crossref",
      "first-page": "334",
      "journal-title": "Addict Biol",
      "key": "1172_CR121",
      "unstructured": "Rouault M, Nielsen DA, Ho A, Kreek MJ, Yuferov V (2011) Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity. Addict Biol 16:334–346",
      "volume": "16",
      "year": "2011"
    },
    {
      "DOI": "10.1093/alcalc/agh151",
      "author": "G Rubio",
      "doi-asserted-by": "crossref",
      "first-page": "227",
      "journal-title": "Alcohol Alcohol",
      "key": "1172_CR122",
      "unstructured": "Rubio G, Ponce G, Rodriguez-Jimenez R, Jimenez-Arriero MA, Hoenicka J, Palomo T (2005) Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? Alcohol Alcohol 40:227–233",
      "volume": "40",
      "year": "2005"
    },
    {
      "author": "K Rutten",
      "first-page": "253",
      "journal-title": "Drug Alcohol Depend",
      "key": "1172_CR123",
      "unstructured": "Rutten K, De Vry J, Bruckmann W, Tzschentke TM (2011) Pharmacological blockade or genetic knockout of the NOP receptor potentiates the rewarding effect of morphine in rats. Drug Alcohol Depend 114:253–256",
      "volume": "114",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1365-2265.2011.03985.x",
      "author": "F Rutters",
      "doi-asserted-by": "crossref",
      "first-page": "679",
      "journal-title": "Clin Endocrinol (Oxf)",
      "key": "1172_CR124",
      "unstructured": "Rutters F, Nieuwenhuizen AG, Lemmens SG, Bouwman F, Mariman E, Westerterp-Plantenga MS (2011) Associations between anthropometrical measurements, body composition, single-nucleotide polymorphisms of the hypothalamus/pituitary/adrenal (HPA) axis and HPA axis functioning. Clin Endocrinol (Oxf) 74:679–686",
      "volume": "74",
      "year": "2011"
    },
    {
      "author": "T Sander",
      "first-page": "2108",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR125",
      "unstructured": "Sander T, Gscheidel N, Wendel B, Samochowiec J, Smolka M, Rommelspacher H, Schmidt LG, Hoehe MR (1998) Human mu-opioid receptor variation and alcohol dependence. Alcohol Clin Exp Res 22:2108–2110",
      "volume": "22",
      "year": "1998"
    },
    {
      "DOI": "10.1038/sj.mp.4000951",
      "author": "JA Schinka",
      "doi-asserted-by": "crossref",
      "first-page": "224",
      "journal-title": "Mol Psychiatry",
      "key": "1172_CR126",
      "unstructured": "Schinka JA, Town T, Abdullah L, Crawford FC, Ordorica PI, Francis E, Hughes P, Graves AB, Mortimer JA, Mullan M (2002) A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol Psychiatry 7:224–228",
      "volume": "7",
      "year": "2002"
    },
    {
      "DOI": "10.1111/j.1530-0277.1998.tb03931.x",
      "author": "JH Schluger",
      "doi-asserted-by": "crossref",
      "first-page": "1430",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR127",
      "unstructured": "Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, Perret G, King A, Kreek MJ (1998) Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. Alcohol Clin Exp Res 22:1430–1436",
      "volume": "22",
      "year": "1998"
    },
    {
      "DOI": "10.1016/j.psyneuen.2011.03.002",
      "doi-asserted-by": "crossref",
      "key": "1172_CR128",
      "unstructured": "Schwandt ML, Lindell SG, Higley JD, Suomi SJ, Heilig M, Barr CS (2011) OPRM1 gene variation influences hypothalamic–pituitary–adrenal axis function in response to a variety of stressors in rhesus macaques. Psychoneuroendocrinology 36:1303–1311"
    },
    {
      "DOI": "10.1111/j.1530-0277.2011.01446.x",
      "author": "E Setiawan",
      "doi-asserted-by": "crossref",
      "first-page": "1134",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR129",
      "unstructured": "Setiawan E, Pihl RO, Cox SM, Gianoulakis C, Palmour RM, Benkelfat C, Leyton M (2011) The effect of naltrexone on alcohol’s stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype. Alcohol Clin Exp Res 35:1134–1141",
      "volume": "35",
      "year": "2011"
    },
    {
      "DOI": "10.1093/hmg/ddn439",
      "author": "SA Shabalina",
      "doi-asserted-by": "crossref",
      "first-page": "1037",
      "journal-title": "Hum Mol Genet",
      "key": "1172_CR130",
      "unstructured": "Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L (2009) Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet 18:1037–1051",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1002/humu.9026",
      "author": "J Shi",
      "doi-asserted-by": "crossref",
      "first-page": "459",
      "journal-title": "Hum Mutat",
      "key": "1172_CR131",
      "unstructured": "Shi J, Hui L, Xu Y, Wang F, Huang W, Hu G (2002) Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum Mutat 19:459–460",
      "volume": "19",
      "year": "2002"
    },
    {
      "DOI": "10.1002/ajmg.b.30105",
      "author": "RJ Smith",
      "doi-asserted-by": "crossref",
      "first-page": "105",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "1172_CR132",
      "unstructured": "Smith RJ, Doyle GA, Han AM, Crowley JJ, Oslin DW, Patkar AA, Mannelli P, DeMaria PA Jr, O’Brien CP, Berrettini WH (2005) Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence. Am J Med Genet B Neuropsychiatr Genet 133B:105–109",
      "volume": "133B",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S0306-4530(99)00017-7",
      "author": "M Smolka",
      "doi-asserted-by": "crossref",
      "first-page": "629",
      "journal-title": "Psychoneuroendocrinology",
      "key": "1172_CR133",
      "unstructured": "Smolka M, Sander T, Schmidt LG, Samochowiec J, Rommelspacher H, Gscheidel N, Wendel B, Hoehe MR (1999) Mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal. Psychoneuroendocrinology 24:629–638",
      "volume": "24",
      "year": "1999"
    },
    {
      "DOI": "10.1111/j.1369-1600.2010.00287.x",
      "author": "JE Sturgess",
      "doi-asserted-by": "crossref",
      "first-page": "357",
      "journal-title": "Addict Biol",
      "key": "1172_CR134",
      "unstructured": "Sturgess JE, George TP, Kennedy JL, Heinz A, Muller DJ (2011) Pharmacogenetics of alcohol, nicotine and drug addiction treatments. Addict Biol 16:357–376",
      "volume": "16",
      "year": "2011"
    },
    {
      "DOI": "10.1097/00001756-200105080-00011",
      "author": "CY Szeto",
      "doi-asserted-by": "crossref",
      "first-page": "1103",
      "journal-title": "NeuroReport",
      "key": "1172_CR135",
      "unstructured": "Szeto CY, Tang NL, Lee DT, Stadlin A (2001) Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. NeuroReport 12:1103–1106",
      "volume": "12",
      "year": "2001"
    },
    {
      "DOI": "10.1097/00001756-200303240-00008",
      "author": "EC Tan",
      "doi-asserted-by": "crossref",
      "first-page": "569",
      "journal-title": "NeuroReport",
      "key": "1172_CR136",
      "unstructured": "Tan EC, Tan CH, Karupathivan U, Yap EP (2003) Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. NeuroReport 14:569–572",
      "volume": "14",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.brainres.2011.02.042",
      "author": "MM Taqi",
      "doi-asserted-by": "crossref",
      "first-page": "18",
      "journal-title": "Brain Res",
      "key": "1172_CR137",
      "unstructured": "Taqi MM, Bazov I, Watanabe H, Nyberg F, Yakovleva T, Bakalkin G (2011) Prodynorphin promoter SNP associated with alcohol dependence forms noncanonical AP-1 binding site that may influence gene expression in human brain. Brain Res 1385:18–25",
      "volume": "1385",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S0006-8993(98)00706-9",
      "author": "M Telkov",
      "doi-asserted-by": "crossref",
      "first-page": "284",
      "journal-title": "Brain Res",
      "key": "1172_CR138",
      "unstructured": "Telkov M, Geijer T, Terenius L (1998) Human prodynorphin gene generates several tissue-specific transcripts. Brain Res 804:284–295",
      "volume": "804",
      "year": "1998"
    },
    {
      "DOI": "10.1111/j.1530-0277.2007.00545.x",
      "author": "JW Tidey",
      "doi-asserted-by": "crossref",
      "first-page": "58",
      "journal-title": "Alcohol Clin Exp Res",
      "key": "1172_CR139",
      "unstructured": "Tidey JW, Monti PM, Rohsenow DJ, Gwaltney CJ, Miranda R Jr, McGeary JE, MacKillop J, Swift RM, Abrams DB, Shiffman S, Paty JA (2008) Moderators of naltrexone’s effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol Clin Exp Res 32:58–66",
      "volume": "32",
      "year": "2008"
    },
    {
      "DOI": "10.1002/(SICI)1096-8628(19991015)88:5\u003c458::AID-AJMG3\u003e3.0.CO;2-S",
      "author": "T Town",
      "doi-asserted-by": "crossref",
      "first-page": "458",
      "journal-title": "Am J Med Genet",
      "key": "1172_CR140",
      "unstructured": "Town T, Abdullah L, Crawford F, Schinka J, Ordorica PI, Francis E, Hughes P, Duara R, Mullan M (1999) Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet 88:458–461",
      "volume": "88",
      "year": "1999"
    },
    {
      "DOI": "10.1080/17470919.2010.482786",
      "author": "A Troisi",
      "doi-asserted-by": "crossref",
      "first-page": "88",
      "journal-title": "Soc Neurosci",
      "key": "1172_CR141",
      "unstructured": "Troisi A, Frazzetto G, Carola V, Di Lorenzo G, Coviello M, D’Amato FR, Moles A, Siracusano A, Gross C (2011) Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (OPRM1) in adult healthy volunteers and psychiatric patients. Soc Neurosci 6:88–97",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s11010-011-0725-5",
      "author": "JT Tuusa",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "journal-title": "Mol Cell Biochem",
      "key": "1172_CR142",
      "unstructured": "Tuusa JT, Petaja-Repo UE (2011) Phe27Cys polymorphism of the human delta opioid receptor predisposes cells to compromised calcium signaling. Mol Cell Biochem 351:173–181",
      "volume": "351",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.drugalcdep.2010.01.005",
      "author": "EJ Vallender",
      "doi-asserted-by": "crossref",
      "first-page": "252",
      "journal-title": "Drug Alcohol Depend",
      "key": "1172_CR143",
      "unstructured": "Vallender EJ, Ruedi-Bettschen D, Miller GM, Platt DM (2010) A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys. Drug Alcohol Depend 109:252–256",
      "volume": "109",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.neubiorev.2003.08.002",
      "author": "MM Vanyukov",
      "doi-asserted-by": "crossref",
      "first-page": "507",
      "journal-title": "Neurosci Biobehav Rev",
      "key": "1172_CR144",
      "unstructured": "Vanyukov MM, Tarter RE, Kirisci L, Kirillova GP, Maher BS, Clark DB (2003) Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci Biobehav Rev 27:507–515",
      "volume": "27",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0893-133X(01)00294-9",
      "author": "GS Wand",
      "doi-asserted-by": "crossref",
      "first-page": "106",
      "journal-title": "Neuropsychopharmacology",
      "key": "1172_CR145",
      "unstructured": "Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S, Ali A (2002) The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26:106–114",
      "volume": "26",
      "year": "2002"
    },
    {
      "DOI": "10.1074/jbc.M104083200",
      "author": "D Wang",
      "doi-asserted-by": "crossref",
      "first-page": "34624",
      "journal-title": "J Biol Chem",
      "key": "1172_CR146",
      "unstructured": "Wang D, Quillan JM, Winans K, Lucas JL, Sadee W (2001) Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding. J Biol Chem 276:34624–34630",
      "volume": "276",
      "year": "2001"
    },
    {
      "author": "JL Weber",
      "first-page": "2200",
      "journal-title": "Nucleic Acids Res",
      "key": "1172_CR147",
      "unstructured": "Weber JL, May PE (1990) Dinucleotide repeat polymorphism at the PENK locus. Nucleic Acids Res 18:2200",
      "volume": "18",
      "year": "1990"
    },
    {
      "DOI": "10.1016/j.brainresbull.2011.02.010",
      "author": "SG Wei",
      "doi-asserted-by": "crossref",
      "first-page": "238",
      "journal-title": "Brain Res Bull",
      "key": "1172_CR148",
      "unstructured": "Wei SG, Zhu YS, Lai JH, Xue HX, Chai ZQ, Li SB (2011) Association between heroin dependence and prodynorphin gene polymorphisms. Brain Res Bull 85:238–242",
      "volume": "85",
      "year": "2011"
    },
    {
      "DOI": "10.1016/0169-328X(95)00096-B",
      "author": "MJ Wick",
      "doi-asserted-by": "crossref",
      "first-page": "342",
      "journal-title": "Brain Res Mol Brain Res",
      "key": "1172_CR149",
      "unstructured": "Wick MJ, Minnerath SR, Roy S, Ramakrishnan S, Loh HH (1995) Expression of alternate forms of brain opioid ‘orphan’ receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Brain Res Mol Brain Res 32:342–347",
      "volume": "32",
      "year": "1995"
    },
    {
      "DOI": "10.1111/j.1369-1600.2007.00069.x",
      "author": "TJ Williams",
      "doi-asserted-by": "crossref",
      "first-page": "496",
      "journal-title": "Addict Biol",
      "key": "1172_CR150",
      "unstructured": "Williams TJ, LaForge KS, Gordon D, Bart G, Kellogg S, Ott J, Kreek MJ (2007) Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence. Addict Biol 12:496–502",
      "volume": "12",
      "year": "2007"
    },
    {
      "DOI": "10.1038/npp.2008.142",
      "author": "W Wittmann",
      "doi-asserted-by": "crossref",
      "first-page": "775",
      "journal-title": "Neuropsychopharmacology",
      "key": "1172_CR151",
      "unstructured": "Wittmann W, Schunk E, Rosskothen I, Gaburro S, Singewald N, Herzog H, Schwarzer C (2009) Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology 34:775–785",
      "volume": "34",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ejphar.2007.03.005",
      "author": "Z Xie",
      "doi-asserted-by": "crossref",
      "first-page": "45",
      "journal-title": "Eur J Pharmacol",
      "key": "1172_CR152",
      "unstructured": "Xie Z, Li Z, Guo L, Ye C, Li J, Yu X, Yang H, Wang Y, Chen C, Zhang D, Liu-Chen LY (2007) Regulator of G protein signaling proteins differentially modulate signaling of mu and delta opioid receptors. Eur J Pharmacol 565:45–53",
      "volume": "565",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ajmg.10374",
      "author": "K Xu",
      "doi-asserted-by": "crossref",
      "first-page": "45",
      "journal-title": "Am J Med Genet",
      "key": "1172_CR153",
      "unstructured": "Xu K, Liu XH, Nagarajan S, Gu XY, Goldman D (2002) Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample. Am J Med Genet 110:45–50",
      "volume": "110",
      "year": "2002"
    },
    {
      "DOI": "10.1111/j.1471-4159.2008.05833.x",
      "author": "J Xu",
      "doi-asserted-by": "crossref",
      "first-page": "962",
      "journal-title": "J Neurochem",
      "key": "1172_CR154",
      "unstructured": "Xu J, Xu M, Hurd YL, Pasternak GW, Pan YX (2009) Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene. J Neurochem 108:962–972",
      "volume": "108",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.mp.4001882",
      "author": "X Xuei",
      "doi-asserted-by": "crossref",
      "first-page": "1016",
      "journal-title": "Mol Psychiatry",
      "key": "1172_CR155",
      "unstructured": "Xuei X, Dick D, Flury-Wetherill L, Tian HJ, Agrawal A, Bierut L, Goate A, Bucholz K, Schuckit M, Nurnberger J Jr, Tischfield J, Kuperman S, Porjesz B, Begleiter H, Foroud T, Edenberg HJ (2006) Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 11:1016–1024",
      "volume": "11",
      "year": "2006"
    },
    {
      "DOI": "10.1002/ajmg.b.30531",
      "author": "X Xuei",
      "doi-asserted-by": "crossref",
      "first-page": "877",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "1172_CR156",
      "unstructured": "Xuei X, Flury-Wetherill L, Bierut L, Dick D, Nurnberger J Jr, Foroud T, Edenberg HJ (2007) The opioid system in alcohol and drug dependence: family-based association study. Am J Med Genet B Neuropsychiatr Genet 144:877–884",
      "volume": "144",
      "year": "2007"
    },
    {
      "DOI": "10.1111/j.1369-1600.2007.00082.x",
      "author": "X Xuei",
      "doi-asserted-by": "crossref",
      "first-page": "80",
      "journal-title": "Addict Biol",
      "key": "1172_CR157",
      "unstructured": "Xuei X, Flury-Wetherill L, Almasy L, Bierut L, Tischfield J, Schuckit M, Nurnberger JI Jr, Foroud T, Edenberg HJ (2008) Association analysis of genes encoding the nociceptin receptor (OPRL1) and its endogenous ligand (PNOC) with alcohol or illicit drug dependence. Addict Biol 13:80–87",
      "volume": "13",
      "year": "2008"
    },
    {
      "DOI": "10.1097/00008571-200412000-00002",
      "author": "V Yuferov",
      "doi-asserted-by": "crossref",
      "first-page": "793",
      "journal-title": "Pharmacogenetics",
      "key": "1172_CR158",
      "unstructured": "Yuferov V, Fussell D, LaForge KS, Nielsen DA, Gordon D, Ho A, Leal SM, Ott J, Kreek MJ (2004) Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics 14:793–804",
      "volume": "14",
      "year": "2004"
    },
    {
      "DOI": "10.1038/npp.2008.187",
      "author": "V Yuferov",
      "doi-asserted-by": "crossref",
      "first-page": "1185",
      "journal-title": "Neuropsychopharmacology",
      "key": "1172_CR159",
      "unstructured": "Yuferov V, Ji F, Nielsen DA, Levran O, Ho A, Morgello S, Shi R, Ott J, Kreek MJ (2009) A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology 34:1185–1197",
      "volume": "34",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1749-6632.2009.05275.x",
      "author": "V Yuferov",
      "doi-asserted-by": "crossref",
      "first-page": "184",
      "journal-title": "Ann N Y Acad Sci",
      "key": "1172_CR160",
      "unstructured": "Yuferov V, Levran O, Proudnikov D, Nielsen DA, Kreek MJ (2010) Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci 1187:184–207",
      "volume": "1187",
      "year": "2010"
    },
    {
      "DOI": "10.1074/jbc.M504942200",
      "author": "Y Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "32618",
      "journal-title": "J Biol Chem",
      "key": "1172_CR161",
      "unstructured": "Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W (2005) Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 280:32618–32624",
      "volume": "280",
      "year": "2005"
    },
    {
      "DOI": "10.1093/hmg/ddl024",
      "doi-asserted-by": "crossref",
      "key": "1172_CR1002",
      "unstructured": "Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang BZ, Krupitsky E, Zvartau E, Gelernter J (2006) Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 15:807–819"
    },
    {
      "DOI": "10.1016/j.biopsych.2006.07.012",
      "author": "D Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "1244",
      "journal-title": "Biol Psychiatry",
      "key": "1172_CR162",
      "unstructured": "Zhang D, Shao C, Shao M, Yan P, Wang Y, Liu Y, Liu W, Lin T, Xie Y, Zhao Y, Lu D, Li Y, Jin L (2007) Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Biol Psychiatry 61:1244–1251",
      "volume": "61",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.mp.4002035",
      "author": "H Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "531",
      "journal-title": "Mol Psychiatry",
      "key": "1172_CR163",
      "unstructured": "Zhang H, Kranzler HR, Yang BZ, Luo X, Gelernter J (2008) The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 13:531–543",
      "volume": "13",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.biopsych.2008.12.021",
      "author": "H Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "128",
      "journal-title": "Biol Psychiatry",
      "key": "1172_CR164",
      "unstructured": "Zhang H, Kranzler HR, Weiss RD, Luo X, Brady KT, Anton RF, Farrer LA, Gelernter J (2009) Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biol Psychiatry 66:128–136",
      "volume": "66",
      "year": "2009"
    },
    {
      "DOI": "10.1038/jhg.2010.22",
      "author": "H Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "278",
      "journal-title": "J Hum Genet",
      "key": "1172_CR165",
      "unstructured": "Zhang H, Gelernter J, Gruen JR, Kranzler HR, Herman AI, Simen AA (2010) Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region. J Hum Genet 55:278–284",
      "volume": "55",
      "year": "2010"
    },
    {
      "DOI": "10.1046/j.1471-4159.2000.740472.x",
      "author": "A Zimprich",
      "doi-asserted-by": "crossref",
      "first-page": "472",
      "journal-title": "J Neurochem",
      "key": "1172_CR166",
      "unstructured": "Zimprich A, Kraus J, Woltje M, Mayer P, Rauch E, Hollt V (2000) An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression. J Neurochem 74:472–477",
      "volume": "74",
      "year": "2000"
    }
  ],
  "reference-count": 168,
  "references-count": 168,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s00439-012-1172-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "The genetics of the opioid system and specific drug addictions"
  ],
  "type": "journal-article",
  "volume": "131"
}